Search results
Results from the WOW.Com Content Network
Cystadenocarcinoma is a malignant form of a cystadenoma and is a cancer derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur.
Mucinous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. It can occur in the breast [1] as well as in the ovary. [2] Tumors are normally multilocular with various smooth, thin walled cysts. Within the cysts is found a haemorrhagic or cellular debris. [2]
The QCancer (Ovary) algorithm is used to predict likelihood of ovarian cancer from risk factors. [31] Ovarian-Adnexal Reporting and Data System (ORADS) is a standardized system developed by the American College of Radiology to improve the management and diagnosis of ovarian and adnexal masses. It provides a consistent framework for interpreting ...
A mutation in BRCA1 or BRCA2 can confer a lifetime ovarian cancer risk of 40-50% and 10-20% respectively, [15] with BRCA2 mutations strongly associated with better clinical outcomes. A specific tumour protein 53 ( TP53 ) expression pattern in the Fallopian tube epithelium – the ‘p53 signature’ - is thought to be a precursor marker of HGSC.
The risk of mucinous tumors is significantly associated with smoking: relative risk for current smokers 2.22 (2.22 times the risk for non-smokers) and 2.02 for past smokers. Risk is also associated with smoking duration: relative risk per 20 years was 1.44. See article by Tworoger SS in Cancer March 1, 2008 using data from the Nurses Health Study.
Pancreatic mucinous cystadenoma or mucinous cystadenoma of the pancreas (MCN) are a type of mucinous cystic neoplasm of the pancreas. [3] The cure rate is very high in cases on benign cystic lesions, but the case changes if malignant changes ensue. [4] Benign cystadenomas are the most common cystic tumors of the pancreas accounting for 75% of ...
Serous cystadenocarcinoma is a serous tumor in the cystadenocarcinoma grouping.. Most commonly, the primary site of serous cystadenocarcinoma is the ovary.Rare occurrence in the pancreas has been reported, although this is not typical, with the majority of microcystic pancreatic masses representing alternate disease processes such as the more benign serous cystadenoma.
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of cancers.